Study of the possible role of cAMP and KATP channels in atorvastatin-induced hepatotoxicity /
Engy Ali Elsayed Mansour
Study of the possible role of cAMP and KATP channels in atorvastatin-induced hepatotoxicity / دراسة الدور المحتمل لادينوسين احادى الفوسفات الحلقي وقنوات البوتاسيوم ادينوسين ثلاثى الفوسفات على التسمم الكبدي الناجم عن اتورفاستاتين Engy Ali Elsayed Mansour ; Supervised Hesham Aly Salem , Sherifa Kamal Ahmed , Suzan Mohamed Mansour - Cairo : Engy Ali Elsayed Mansour , 2019 - 113 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
Atorvastatin (ATO), a 3-hydroxy-3-methylglutryl-CoA reductase inhibitor, is used widely for treatment of hypercholesterolemia and hypertriglyceridemia. The full clinical utility of ATO has now been somehow limited because of ATO-associated several acute and chronic side effects.The aim of the present work was to investigate the possible mechanism by which cyclic adenosine monophosphate (cAMP) induction or KATP channel opening might affect ATO-induced hepatotoxicity.1- Preliminary study: to determine the most appropriate hepatotoxic regimen (dose and duration) of ATO,depending on measuring alanine transaminase (ALT) and aspartate transaminase (AST) in addition to histopathological liver examination, was performed
cAMP and KATP cAMP and KATP channels Hepatotoxicity
Study of the possible role of cAMP and KATP channels in atorvastatin-induced hepatotoxicity / دراسة الدور المحتمل لادينوسين احادى الفوسفات الحلقي وقنوات البوتاسيوم ادينوسين ثلاثى الفوسفات على التسمم الكبدي الناجم عن اتورفاستاتين Engy Ali Elsayed Mansour ; Supervised Hesham Aly Salem , Sherifa Kamal Ahmed , Suzan Mohamed Mansour - Cairo : Engy Ali Elsayed Mansour , 2019 - 113 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology
Atorvastatin (ATO), a 3-hydroxy-3-methylglutryl-CoA reductase inhibitor, is used widely for treatment of hypercholesterolemia and hypertriglyceridemia. The full clinical utility of ATO has now been somehow limited because of ATO-associated several acute and chronic side effects.The aim of the present work was to investigate the possible mechanism by which cyclic adenosine monophosphate (cAMP) induction or KATP channel opening might affect ATO-induced hepatotoxicity.1- Preliminary study: to determine the most appropriate hepatotoxic regimen (dose and duration) of ATO,depending on measuring alanine transaminase (ALT) and aspartate transaminase (AST) in addition to histopathological liver examination, was performed
cAMP and KATP cAMP and KATP channels Hepatotoxicity